Comparative Superiority of ACE Inhibitors Over Angiotensin Receptor Blockers for People With CKD: Does It Matter?  Dimitris Mavridis, PhD  American Journal of Kidney Diseases  Volume 67, Issue 5, Pages 713-715 (May 2016) DOI: 10.1053/j.ajkd.2016.02.031 Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions

Figure 1 Boxplots show the distribution of publication year in angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) versus placebo/active control. Boxes show the first and third quartiles of the publication year; the horizontal line inside the box shows the second quartile (median). The ends of the whiskers outside the boxes show minimum and maximum publication years. American Journal of Kidney Diseases 2016 67, 713-715DOI: (10.1053/j.ajkd.2016.02.031) Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions